Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study to Evaluate the Safety and Efficacy of AIV001 Intradermally Administered in Subjects With Biopsy-confirmed Basal Cell Carcinoma

NCT04470726 is registered in ClinicalTrials.gov with AiViva BioPharma, Inc. as lead sponsor.

NCT NCT04470726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04470726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study to Evaluate the Safety and Efficacy of AIV001 Intradermally Administered in Subjects With Biopsy-confirmed Basal Cell Carcinoma
Lead sponsor
AiViva BioPharma, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
August 18, 2020
Completion date
July 28, 2023
Enrollment
26 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nodular basal cell carcinoma, nonmelanoma skin cancers, superficial basal cell carcinoma